Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial
{{output}}
Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients aged between 1 and 15 y... ...
